Long COVID remains a major diagnostic and treatment gap today. Millions of Americans battle severe and persistent symptoms each day.
Recent research shows a hidden change could drive these symptoms. Researchers assessed blood samples from Long COVID patients. They found abnormal changes in microscopic blood structures linked to common symptoms like brain fog and fatigue.
These findings could guide future therapies that address this gap. The study found strong links between these biomarkers and Long COVID. The biomarkers appear connected to thrombo-inflammatory activity in the body.
Thrombo-inflammatory activity involves blood clots triggered by inflammation. Inflammation can develop due to disease and immune responses.





